scispace - formally typeset
Open AccessJournal ArticleDOI

Transcription abnormalities potentiate apoptosis of normal human fibroblasts

Reads0
Chats0
TLDR
Results show that there is a link between defective transcription and apoptosis and transcription inhibitors increase p53 levels and are better inducers of apoptosis than DNA-damaging agents in some cell types.
Abstract
Apoptosis is a natural process by which damaged and potentially tumorigenic cells are removed Induction of apoptosis is important in chemotherapy aimed at eliminating cancer cells We address the mechanisms by which this process can be triggered in cells that are recalcitrant to cell death induced by DNA-damaging agents Normal human fibroblasts and lymphoblasts, and fibroblasts with defined genetic changes, were treated with DNA-damaging agents and inhibitors of transcription Western blotting was used to study the expression of some of the key factors involved in the response to DNA damage and the induction of apoptosis, namely, p53, p21WAF1,Cip1, Mdm2, Bax, and CD95 (Fas/APO1) Apoptosis was followed by various criteria, including DNA fragmentation, specific proteolysis, cell morphology, viability, and FACS scan for sub-G1 cells Normal human fibroblasts were more resistant than lymphoblasts to DNA damage-induced apoptosis The DNA-damaging agents mitomycin C and cisplatin induced rapid apoptosis of fibroblasts with defects in the repair of transcribed DNA, compared with wild-type cells or those with defects in overall genome repair Short-term treatment with inhibitors of RNA polymerase II transcription, actinomycin D, and α-amanitin induced rapid cell death of normal fibroblasts These results show that there is a link between defective transcription and apoptosis Treatments and genetic backgrounds that favored apoptosis were associated with efficient and prolonged induction of p53 and often altered or unbalanced expression of its downstream effectors p21WAF1,Cip1 and Mdm2, whereas there were no changes in Bax or CD95 (Fas/APO1) Transcription inhibitors increase p53 levels and are better inducers of apoptosis than DNA-damaging agents in some cell types Apoptosis might be triggered by blocked polymerases and/or faulty expression of downstream effectors

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

DNA damage and the balance between survival and death in cancer biology

TL;DR: This Review described key decision-making nodes in the complex interplay between cell survival and death following DNA damage, which determine the outcome of cancer therapy with genotoxic drugs.
Journal ArticleDOI

Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses

TL;DR: It is proposed that the nucleolus is a stress sensor responsible for maintenance of low levels of p53, which are automatically elevated as soon as nucleolar function is impaired in response to stress.
Journal ArticleDOI

Inhibition of RNA polymerase II as a trigger for the p53 response

TL;DR: The results suggest that the induction of the p53 response by certain toxic agents is not triggered by DNA strand breaks but rather, may be linked to inhibition of mRNA synthesis either directly by the poisoning of RNA polymerase II or indirectly byThe induction of elongation-blocking DNA lesions.
Journal ArticleDOI

Transcription - guarding the genome by sensing DNA damage.

TL;DR: There is recent evidence that the transcription machinery might be used in DNA-damage surveillance and in triggering DNA- damage responses to suppress mutagenesis, and transcription might also act as aDNA-damage dosimeter where the severity of blockage determines whether or not to induce cell death.
Journal Article

Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.

TL;DR: Vitamin E succinate is a potent and highly specific anticancer agent and/or adjuvant of considerable therapeutic potential and exerted a cooperative proapoptotic activity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in suppression of tumor growth in vivo.
References
More filters
Journal ArticleDOI

WAF1, a potential mediator of p53 tumor suppression

TL;DR: A gene is identified, named WAF1, whose induction was associated with wild-type but not mutant p53 gene expression in a human brain tumor cell line and that could be an important mediator of p53-dependent tumor growth suppression.
Journal ArticleDOI

p53, the Cellular Gatekeeper for Growth and Division

TL;DR: The author regrets the lack of citations for many important observations mentioned in the text, but their omission is made necessary by restrictions in the preparation of review manuscripts.
Journal ArticleDOI

Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis

TL;DR: The effects of dominant-interfering or constitutively activated forms of various components of the JNK-p38 and ERK signaling pathways demonstrated that activation of JNK and p38 and concurrent inhibition of ERK are critical for induction of apoptosis in these cells.
Journal ArticleDOI

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

TL;DR: The reliability and sensitivity of the test have been increased to the point where it can in many cases replace the [3H]thymidine uptake assay to measure cell proliferation or survival in growth factor or cytotoxicity assays.
Journal ArticleDOI

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

TL;DR: The bax gene promoter region contains four motifs with homology to consensus p53-binding sites and wild-type but not mutant p53 protein bound to oligonucleotides corresponding to this region of the bax promoter, suggesting that bax is a p53 primary-response gene, presumably involved in a p 53-regulated pathway for induction of apoptosis.
Related Papers (5)